Trial intelligence / Profile preview

Hyaluronic acid versus lidocaine for pes anserine tendinopathy of the knee

RBR-10d49f9tCompleted

Sponsor
IAMSPE
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of lidocaine in pes anserine syndrome (2 arms), sponsored by IAMSPE. Primary endpoint: Primary endpoint not reported. Started Nov 2025; status: completed.

02

Drugs

lidocaine
03

Conditions

pes anserine syndrome

Beyond the preview

Go deeper on RBR-10d49f9t.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-10d49f9t.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call